Preterm birth is a major cause of neonatal death and cerebral palsy. This grant will provide proof-of-concept that a computer program can be developed to predict a pregnant woman�s risk of preterm birth. There is a large market (4M US and 8M Europe), there are no competing technologies. This is a unique collaboration between Biomedical Engineering and an Australian centre with an international reputation in preterm birth, assisted by a pathology company.
Economic impact and policy implications of assisted reproductive technologies in Australia. Assisted reproductive technology (ART) is now a large scale economic activity in Australia, provided almost exclusively by private clinics. The outcome of ART programs, involving the birth of one in 30 children, has a profound effect on the health of the nation. Policy and funding frameworks influence how ART is practiced and the subsequent health outcomes of ART children, yet there is a lack of evidence ....Economic impact and policy implications of assisted reproductive technologies in Australia. Assisted reproductive technology (ART) is now a large scale economic activity in Australia, provided almost exclusively by private clinics. The outcome of ART programs, involving the birth of one in 30 children, has a profound effect on the health of the nation. Policy and funding frameworks influence how ART is practiced and the subsequent health outcomes of ART children, yet there is a lack of evidence to guide government and providers about effective, equitable and safe approaches to funding ART. This research will address that need, thereby fostering a healthy start to life and preventative healthcare; supporting the National Research Priority, promoting and maintaining good health, for ART children, their families and the community.Read moreRead less
Life-saving chemo/radio-therapy commonly renders women and girls who survivor cancer infertile or sterile. We have discovered a new means of preserving the fertility of female mice exposed to chemo/radio therapy. In this project we will apply these advances to human ovarian tissue/eggs for the first time. We have access to these rare tissues for research purposes. This project will develop new approaches to fertility preservation for cancer survivors.